Publication Name	World Journal of Transplantation
Manuscript ID	34484
Country	United States

Received	2017-04-28 09:27
Peer-Review Started	2017-04-28 14:15
To Make the First Decision	2017-06-14 00:47
Return for Revision	2017-06-16 05:49
Revised	2017-06-30 21:05
Second Decision	2017-09-06 08:21
Accepted by Journal Editor-in-Chief	2017-09-06 15:03
Accepted by Company Editor-in-Chief	2017-09-13 19:24
Articles in Press	2017-09-13 19:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-10-23 06:31
Publish the Manuscript Online	2017-10-23 07:26

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?
Manuscript Source	Invited Manuscript
All Author List	Whitney D Wallis and Muzaffar H Qazilbash
ORCID	Author(s) ORCID Number Whitney D Wallis http://orcid.org/0000-0002-6233-8811 Muzaffar H Qazilbash http://orcid.org/0000-0003-2876-2886
Funding Agency and Grant Number
Corresponding Author	Muzaffar H Qazilbash, MD, the University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. mqazilba@mdanderson.org
Key Words	Multiple myeloma; Stem cell; Mobilization; Growth factors; Chemotherapy
Core Tip	Obtaining an adequate peripheral blood stem cell yield is essential for the successful outcome of autologous hematopoietic stem cell transplant in multiple myeloma. While growth factor mobilization continues to be largely successful, suboptimal collection rates have been noted, particularly as use of novel therapies continue to increase. Chemomobilization remains toxic and has not been associated with better disease control. The newest mobilizing agent, plerixafor, is capable of overcoming suboptimal mobilization even in patients who are at a high risk of mobilization failure. Each mobilization strategy should be selected based on patient specific variables as well as risk factors for mobilization failure.
Publish Date	2017-10-23 07:26
Citation	Wallis WD, Qazilbash MH. Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy? World J Transplant 2017; 7(5): 250-259
URL	http://www.wjgnet.com/2220-3230/full/v7/i5/250.htm
DOI	http://dx.doi.org/10.5500/wjt.v7.i5.250

Full Article (PDF)	WJT-7-250.pdf
Full Article (Word)	WJT-7-250.doc
Manuscript File	34484-Review.docx
Answering Reviewers	34484-Answering reviewers.pdf
Audio Core Tip	34484-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	34484-Conflict-of-interest statement.pdf
Copyright License Agreement	34484-Copyright assignment.pdf
Peer-review Report	34484-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	34484-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	34484-Scientific misconduct check.pdf
Scientific Editor Work List	34484-Scientific editor work list.pdf